Outcomes of systemic Janus kinase inhibitors following prior dupilumab use for atopic dermatitis: An evidence-based review

被引：0
|
作者：
Sood, Siddhartha [1 ]
Bagit, Ahmed [1 ,2 ]
Heung, Martin [3 ]
Maliyar, Khalad
Abduelmula, Abrabim [3 ]
Sachdeva, Muskaan [3 ]
Georgakopoulos, Jorge R. [3 ]
Mufti, Asfandyar [3 ,4 ]
Prajapati, Vimal H. [5 ,6 ,7 ,8 ,9 ,10 ]
Yeung, Jensen [3 ,4 ,10 ,11 ]
机构：
[1] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada
[2] McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada
[3] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada
[4] Sunnybrook Hlth Sci Ctr, Dept Dermatol, Toronto, ON, Canada
[5] Univ Calgary, Dept Med, Div Dermatol, Calgary, AB, Canada
[6] Dermatol Res Inst, Calgary, AB, Canada
[7] Skin Hlth & Wellness Ctr, Calgary, AB, Canada
[8] Univ Calgary, Dept Pediat, Sect Community Pediat, Calgary, AB, Canada
[9] Univ Calgary, Dept Pediat, Sect Pediat Rheumatol, Calgary, AB, Canada
[10] Prob Med Res, Waterloo, ON, Canada
[11] Womens Coll Hosp, Dept Dermatol, 76 Grenville St,5th floor, Toronto, ON M5S 1B2, Canada
来源：
JAAD INTERNATIONAL | 2024年 / 16卷
关键词：
abrocitinib; atopic dermatitis; bariciti-; nib; dupilumab; evidence-based; Janus kinase inhibitor; systematic review; upadacitinib;
D O I：
10.1016/j.jdin.2024.03.023
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：31 / 33
页数：3
相关论文
共 50 条
  • [31] The efficacy of Janus kinase inhibitors in patients with atopic dermatitis: A systematic review and network meta-analysis
    Zhang, Lu
    Wang, Lian
    Jiang, Xian
    DERMATOLOGIC THERAPY, 2021, 34 (05)
  • [32] The efficacy and safety of Janus kinase inhibitors in patients with atopic dermatitis: A systematic review and meta-analysis
    Chen, Jingsi
    Cheng, Jun
    Yang, Huan
    Tu, Wei
    Zhang, Yan
    Luo, Xiaoyan
    Wang, Hua
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (02) : 495 - 496
  • [33] A review of major adverse cardiovascular events in patients with atopic dermatitis treated with oral Janus kinase inhibitors
    不详
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (04) : E69 - E69
  • [34] Efficacy and Safety of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis
    Li, Chenyang
    Sun, Xun
    Zhao, Kun
    Meng, Fanxiang
    Li, Lin
    Mu, Zhenzhen
    Han, Xiuping
    DERMATOLOGY, 2022, 238 (04) : 725 - 735
  • [35] Comparison between dupilumab and oral Janus kinase inhibitors in the treatment of prurigo nodularis with or without atopic dermatitis in a tertiary care center in Singapore
    Yew, Yik Weng
    Yeo, Pei Ming
    JAAD INTERNATIONAL, 2023, 13 : 13 - 14
  • [36] Risk of herpetic and non-herpetic cutaneous infections in adult patients with atopic dermatitis exposed to oral janus kinase inhibitors or dupilumab
    Michelen-Gomez, E. A.
    Chiesa Fuxench, Z. C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S39 - S39
  • [37] An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis
    Klein, PA
    Clark, RAF
    ARCHIVES OF DERMATOLOGY, 1999, 135 (12) : 1522 - 1525
  • [38] Updating the NHSHTA systematic review on evidence-based treatments of atopic dermatitis
    Williams, H
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (03) : 606 - 606
  • [39] Janus Kinase Inhibitor Therapy for Cicatricial Alopecias: An Evidence-Based Review
    Sood, Siddhartha
    Bagit, Ahmed
    Seeburruth, Darshana
    Sachdeva, Muskaan
    Maliyar, Khalad
    Abduelmula, Abrahim
    Lytvyn, Yuliya
    Mufti, Asfandyar
    Yeung, Jensen
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024, 28 (05) : 505 - 506
  • [40] A detailed look at the European Medicines Agency's recommendations for use of Janus kinase inhibitors in patients with atopic dermatitis
    Wollenberg, Andreas
    Thyssen, Jacob P.
    Bieber, Thomas
    Chan, Gary
    Kerkmann, Urs
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (10) : 2041 - 2046
12345